MiMedx Group Inc (NASDAQ:MDXG) fell 0.5% during trading on Thursday . The company traded as low as $5.47 and last traded at $5.53. 109,293 shares changed hands during trading, a decline of 96% from the average session volume of 3,086,706 shares. The stock had previously closed at $5.50.
A number of research firms have recently commented on MDXG. Lake Street Capital set a $12.00 price target on MiMedx Group and gave the stock a “buy” rating in a research report on Wednesday, February 21st. BidaskClub lowered MiMedx Group from a “hold” rating to a “sell” rating in a research report on Wednesday, February 28th. Craig Hallum reaffirmed a “buy” rating on shares of MiMedx Group in a research report on Tuesday, February 27th. Needham & Company LLC reaffirmed a “hold” rating on shares of MiMedx Group in a research report on Thursday, March 15th. Finally, ValuEngine lowered MiMedx Group from a “sell” rating to a “strong sell” rating in a research report on Wednesday, May 2nd. Three investment analysts have rated the stock with a sell rating, two have assigned a hold rating and two have given a buy rating to the company’s stock. The company has an average rating of “Hold” and an average price target of $16.00.
The stock has a market cap of $665.10 million, a PE ratio of 28.52, a P/E/G ratio of 0.78 and a beta of 1.53.
About MiMedx Group
MiMedx Group, Inc, a biopharmaceutical company, develops and markets regenerative biologics utilizing human placental tissue allografts with patent-protected processes for various sectors of healthcare. It processes the human placental tissue utilizing its proprietary PURION Process to produce allografts.
Receive News & Ratings for MiMedx Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MiMedx Group and related companies with MarketBeat.com's FREE daily email newsletter.